All
This Wasn't the Plan: The Truth
In part 2 of “This Wasn't the Plan,” a young woman recalls her stage 4 blood cancer diagnosis and how chemotherapy revealed unexpected reserves of strength.
Living With Intention After a Cancer Diagnosis
Valarie Traynham discusses some of ways her life has changed since being diagnoses with cancer, and what parts of her identity have remained the same.
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA approvals and priority reviews.
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?
After years of survivorship, I’m realizing that shedding extra pounds may do more than improve comfort — it could reduce my risk of recurrence.
The Hidden Cost of Cancer: Time Toxicities and Insurance Delays
Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, highlighting the need for reform.
What is on the Horizon for Kidney Cancer?
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
GIST Expert Urges Patients to Seek Specialized Second Opinions
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Living with Cancer Taught Me Strength, Wage Theft Taught Me Silence
Diagnosed with incurable cancer in her 20s, Nathalie Jean rebuilt broken systems in public service — only to face wage theft and silence after success.
What Does National Cancer Survivors Month Mean to You?
CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?
June Genitourinary Cancer Highlights: Top 5 Updates Patients Should Know
June brought genitourinary cancer updates, and CURE is sharing the latest in kidney cancer treatment, as well as FDA approvals, cancer vaccines and more.
This Wasn't the Plan: When the World Shifted After Cancer
At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope.
A Reflection on Hope from a Cancer Survivor
I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and emotional survival.
A Veteran Reflects on CAR T-Cell Therapy and Isolation
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
June Prostate Cancer Highlights: Top 5 Updates Patients Should Know
June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data on the role of AI in care.
Saying No to Shapewear After a Double Mastectomy
After having a double mastectomy to rid myself of cancer, I’m less picky about how I look and won’t be wearing uncomfortable shapewear for a wedding.
FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and multiple myeloma, respectively.
CAR T Transforms Treatment Landscape for Blood Cancers
CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, says Dr. André Goy.
Side Effects of BGB-16673 Appear Manageable in Early CLL Study
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
It’s Me, A Cancer Survivor, I Refuse to Be Ignored
I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who won’t be ignored.
A Cancer Thriver Breaks Down Her Definition of Survivorship
Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.
June Blood Cancer Highlights: Top 5 Updates Patients Should Know
June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.
Making Prostate Cancer Easier to Understand for Newly Diagnosed Patients
Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care.
Caring for Patients With Cancer Beyond Remission
I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and emotional challenges.
FDA Grants Priority Review to Revuforj for Mutant NPM1 AML
The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.
Eating Tips for When Cancer Treatment Makes Meals Challenging
Greek yogurt, egg salad, avocado and mac and cheese are easy-to-swallow, high-calorie foods that can help patients maintain strength during cancer treatment.
When Cancer Advocacy Becomes a Lifeline
Cancer survivor Morgan Newman shares how self-advocacy helped her overcome barriers to care and find the support she needed after treatment.
CAR T-Cell Therapy Leads to Remission in Retired Air Force Pilot With Lymphoma
Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.
June Breast Cancer Highlights: Top 5 Updates Patients Should Know
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
Traveling with Multiple Myeloma: A Journey of Adaptation and Hope
I share how traveling fueled my passion for life, how myeloma changed my journeys, and how new mobility options have opened doors to adventure and connection.
What Patients With GIST Should Know About Their Disease
Dr. Breelyn Wilky discusses some of the most recent advancements in GIST treatment, as well as touched on the role of personalized therapy.
